HC Wainwright & Co. Reiterates Buy on Immunocore Hldgs, Maintains $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating for Immunocore Holdings (NASDAQ:IMCR) and maintained a $100 price target.
May 24, 2024 | 4:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating for Immunocore Holdings (NASDAQ:IMCR) and maintained a $100 price target.
The reiteration of a Buy rating and the maintenance of a $100 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100